Adverse Drug Reaction News Bulletins
ADR News Bulletin 2013 August (Volume 15 Number 2)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
1 August 2013
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Recommendations for HLA-B*1502 genotype testing prior to initiation of carbamazepine in new patients
Intravenous iron preparations and risk of allergic reactions
Restricted indications and new contraindication for trimetazidine-containing products
Adulterated health products detected from post-marketing surveillance programme
FAQs on the testing of suspected adulterated health products
HSA website revamp: YOUR Website, YOUR Views!
Increase in antibody-mediated Pure Red Cell Aplasia (PRCA) cases with subcutaneous administration of Eprex® (epoetin alfa) in Singapore
Potential interaction between warfarin and health supplements containing vitamin K
Click on the link below to download the issue in pdf: